Clinical Trial Update: A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing a new dosing regimen of a clot-dissolving drug for prosthetic valve thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Valve Thrombosis

Drugs mentioned

• Clot-dissolving drug (experimental)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Prosthetic Valve Thrombosis | Phase 3 | Status: COMPLETED